The effect of Clidinium c on peptic ulcer treatment
Phase 2
- Conditions
- peptic ulcer.gastroduodenal ulcer NOS peptic ulcer NOS
- Registration Number
- IRCT2013041112977N1
- Lead Sponsor
- Vice chancellor for research, Golestan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
Patients with peptic ulcer in endoscopy and positive rapid urease test for helicobacter pylori (HP) infection are enrolled.
Exclusion criteria: Patients that are taking non steroid anti-inflammatory drugs (NSAIDs), proton pump inhibitors (PPIs), bismuth preparations or antibiotics during the last four weeks and with prior HP eradication, glaucoma, prostatic hypertrophy, pregnancy , lactation and intolerable side effects of clidinium-c are excluded.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Helicobacter pylori eradication. Timepoint: Before and 8 weeks after intervention. Method of measurement: Before intervention in antrum sample with rapid urease test and 8 weeks after intervention with urease breathe test.
- Secondary Outcome Measures
Name Time Method Age. Timepoint: Before intervention. Method of measurement: Year-Birth certificate.;Sex. Timepoint: Before intervention. Method of measurement: Female/male-Observation.